Effect of Agnihotra Ash against Multiple Drug...

Effect of Agnihotra Ash against Multiple Drug Resistant Clinical Isolates

Author Name : Miss. Pratiksha Pradip Pathak, Miss Rachana R. Pachori

ABSTRACT Twice a day during the Vedic period, Brahmin and Vaishya families have historically observed Agnihotra, a Vedic ritual that involves presenting ghee or cooked milk to a sacred fire. Agnihotra's roots are in the pan-IndoIranian lineage, and it is comparable to the Zoroastrian Yasna Haptanhāiti rite. Research suggests that Agnihotra, practised at sunrise and sunset in a copper pyramid, provides a religious method of re-establishing equilibrium between people and their surroundings. Its all- encompassing benefits include microbial flora resistance, wound healing, and promoting balance in many facets of life. Agnihotra's potential to sterilize settings, lower the microbial load, and reduce pollutants in medical isolation rooms is supported by research. Agnihotra ash is thought to improve soil fertility, demonstrating the plant's adaptability in farming methods. However, research regarding use of Agnihotra ash against human pathogens has not been traced. Hence, taking this into consideration, the present study focus on the effect of Agnihotra ash against clinical isolates. In the present study, clinical samples viz. urine, blood and pus was use to isolate pathogens and the antibiotic sensitivity testing was performed for the screening of MDR clinical isolates. Four different Agnihotra ash viz. Ash1 (morning ash with mantra), Ash2 (evening ash with mantra), Ash3 (morning ash without mantra), and Ash4 (evening ash without mantra) was analysed against MDR pathogens. The findings suggest that Ash derived from Agnihotra rituals, particularly from morning sessions accompanied by mantras, exhibited antimicrobial properties. Variations in mantras may impact the range of antimicrobial effectiveness. Agnihotra ash shows promising results in inhibiting the MDR pathogens. Hence, Agnihotra ash could be utilize as natural therapeutic agent for disease treatment.